Automated Inhaler Monitoring for Asthma Medication Usage

NANot yet recruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

March 1, 2026

Conditions
Asthma
Interventions
DEVICE

Smart Inhaler Monitoring Platform for Asthma Management

"The intervention utilizes the aflo™ digital platform, a comprehensive system designed to improve asthma management through advanced technology. It integrates the following components:~1. Electronic Inhaler Sensor: The sensor attaches to a metered-dose inhaler (MDI) and a spacer (if applicable) to automate and provide feedback on the six critical steps of proper inhaler technique, such as shaking the inhaler, breathing out, inhaling slowly, and holding the breath. The sensor also records and stores medication usage data securely.~2. Mobile Application: The app delivers real-time notifications and feedback on inhaler technique, sends reminders for daily controller medication, tracks asthma symptoms, and provides monthly Asthma Control Test (ACT) assessments. It also offers reminders for spacer cleaning and customizable alerts for caregivers.~3. Clinician Portal: Data collected from the sensor and app is accessible via a secure clinician portal, enabling healthcare providers to monitor pa"

Trial Locations (1)

02115

Boston Children's Hospital, Boston

All Listed Sponsors
collaborator

Respiratory Analytics Ltd

UNKNOWN

lead

Boston Children's Hospital

OTHER

NCT06825871 - Automated Inhaler Monitoring for Asthma Medication Usage | Biotech Hunter | Biotech Hunter